Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.
Rasmussen TA, McMahon J, Chang JJ, Symons J, Roche M, Dantanarayana A, Okoye A, Hiener B, Palmer S, Lee WS, Kent SJ, Van Der Weyden C, Prince HM, Cameron PU, Lewin SR.
Rasmussen TA, et al. Among authors: van der weyden c.
AIDS. 2017 Aug 24;31(13):1839-1845. doi: 10.1097/QAD.0000000000001540.
AIDS. 2017.
PMID: 28514279
Free PMC article.